BioXcel Therapeutics (BTAI) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.05 Bn | 197.06 Bn | 7.24 Bn | 544.00 Mn |
| 2 | Gilead Sciences | 181.07 Bn | 177.90 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.15 Bn | 124.30 Bn | 2.84 Bn | 255.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 106.00 Mn |
| 5 | Argenx Se | 61.74 Bn | 56.55 Bn | 1.37 Bn | 66.03 Mn |
| 6 | Moderna | 54.51 Bn | 49.37 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.05 Bn | 30.74 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 148.70 Mn |
| 9 | Roivant Sciences | 29.88 Bn | 29.88 Bn | 1.16 Mn | 720.78 Mn |
| 10 | BioXcel Therapeutics | 2.19 Mn | 2.19 Mn | 160,000.00 | 30.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.30 Mn |
| Mar 31, 2026 | 23.57 Mn |
| Dec 31, 2025 | 12.21 Mn |
| Sep 30, 2025 | 14.20 Mn |
| Jun 30, 2025 | 7.84 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.75 Mn |